Additionally, because Saito et al.[31] showed that HGF gene therapy reduced lymphedema volume in the rat tail lymphedema model created by lymphatic vessel disruption, we expected the mother to harbor the HGF gene mutation, making her susceptible to her diagnosed acquired or en tarda form of lymphedema. Here, HGF is linked to lymphedema.